Land O'Lakes Workshop on Microsampling : Enabling Broader Adoption
The microsampling workshop generated recommendations pertaining to blood sampling site (venous blood versus capillary blood), when to conduct a bridging study, statistical approaches to establish correlation/concordance and deciding on sample size, opportunities and challenges with patient-centric sampling, and how microsampling technology can enrich clinical drug development. Overall, the goal was to provide clarity and recommendations and enable the broader adoption of microsampling supporting patients' needs, convenience, and the transformation from clinic-centric to patient-centric drug development. The need and adoption of away-from-clinic sampling techniques has become critical to maintain patient safety during the current COVID-19 pandemic.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
The AAPS journal - 22(2020), 6 vom: 23. Okt., Seite 135 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wickremsinhe, Enaksha R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bridging study |
|---|
| Anmerkungen: |
Date Completed 06.11.2020 Date Revised 10.01.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1208/s12248-020-00524-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM31666877X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM31666877X | ||
| 003 | DE-627 | ||
| 005 | 20231225161603.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1208/s12248-020-00524-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1055.xml |
| 035 | |a (DE-627)NLM31666877X | ||
| 035 | |a (NLM)33098040 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wickremsinhe, Enaksha R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Land O'Lakes Workshop on Microsampling |b Enabling Broader Adoption |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.11.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The microsampling workshop generated recommendations pertaining to blood sampling site (venous blood versus capillary blood), when to conduct a bridging study, statistical approaches to establish correlation/concordance and deciding on sample size, opportunities and challenges with patient-centric sampling, and how microsampling technology can enrich clinical drug development. Overall, the goal was to provide clarity and recommendations and enable the broader adoption of microsampling supporting patients' needs, convenience, and the transformation from clinic-centric to patient-centric drug development. The need and adoption of away-from-clinic sampling techniques has become critical to maintain patient safety during the current COVID-19 pandemic | ||
| 650 | 4 | |a Congress | |
| 650 | 4 | |a bridging study | |
| 650 | 4 | |a capillary blood | |
| 650 | 4 | |a correlation | |
| 650 | 4 | |a finger prick | |
| 650 | 4 | |a microsampling | |
| 650 | 4 | |a patient-centric sampling | |
| 700 | 1 | |a Ji, Qin C |e verfasserin |4 aut | |
| 700 | 1 | |a Gleason, Carol R |e verfasserin |4 aut | |
| 700 | 1 | |a Anderson, Melanie |e verfasserin |4 aut | |
| 700 | 1 | |a Booth, Brian P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The AAPS journal |d 2004 |g 22(2020), 6 vom: 23. Okt., Seite 135 |w (DE-627)NLM154144304 |x 1550-7416 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2020 |g number:6 |g day:23 |g month:10 |g pages:135 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1208/s12248-020-00524-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2020 |e 6 |b 23 |c 10 |h 135 | ||